The clinical trials below are available in the specialty you selected. Choose a different specialty.
Smoking Asthmatics Research Study
Asthma patients who also smoke are needed to take part in a research study at the Duke Clinical Research Unit. The study will examine whether questionnaires used to evaluate asthma symptoms in non-smokers can also be applied to people with asthma who smoke. Participation will require 2 clinic visits that are approximately 6 weeks apart. (REF# 41549)
Adult ADHD Medication Study
A nationwide research study of a new investigational drug for adults with ADHD. Duke University Medical Center in Durham, NC, will conduct this study. Study-related evaluations and study drug will be provided at no cost to those who qualify. (REF# 00042466)
Asthma Patient Registry
The Duke Clinical Research Unit is enrolling people with asthma into the American Lung Association's Asthma Clinical Research Center patient registry. (REF# 18719)
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects with Gout who have had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
To determine the efficacy of an investigational new medication, lesinurad, when used in combination with allopurinol compared to using allopurinol alone.
Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients with Asthma
Asthma patients who do not smoke and have been using medication for at least a year are needed to take part in a research study at the Duke Clinical Research Unit. (REF# 34572)
Long-Acting Beta Agonist Step Down Study (LASST)
Males and females, age 12 years and older are needed to participate in a research study to evaluate the optimal treatment strategy for reducing therapy in people with asthma. (REF# Pro00034544)
Meningococcal B Disease Vaccine Study in Children 10 to 12 Years Old
Children between the ages of 10 and 12 are needed for a study to examine the effectiveness of a meningitis vaccine. (REF# 27106)